2011
DOI: 10.1117/12.876401
|View full text |Cite
|
Sign up to set email alerts
|

Catheter-based ultrasound hyperthermia with HDR brachytherapy for treatment of locally advanced cancer of the prostate and cervix

Abstract: A clinical treatment delivery platform has been developed and is being evaluated in a clinical pilot study for providing 3D controlled hyperthermia with catheter-based ultrasound applicators in conjunction with high dose rate (HDR) brachytherapy. Catheter-based ultrasound applicators are capable of 3D spatial control of heating in both angle and length of the devices, with enhanced radial penetration of heating compared to other hyperthermia technologies. Interstitial and endocavity ultrasound devices have bee… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
25
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
2

Relationship

4
5

Authors

Journals

citations
Cited by 18 publications
(25 citation statements)
references
References 6 publications
0
25
0
Order By: Relevance
“…1,2 For maximum clinical benefit, uniform temperature profiles are desired within target volumes for 30 -60 min duration, with minimum temperature greater than 40 o C and 6 -10 min cumulative thermal dose at 43 o C. [3][4][5] Administering hyperthermia to tumors situated deep inside the body presents significant clinical challenges such as, selective energy deposition within the tumor while thermally sparing surrounding structures, and sufficient thermometry for reliable treatment monitoring. 6 These difficulties are also associated with hyperthermia delivery to focal tumors in prostate and other organs inside the pelvic cavity.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…1,2 For maximum clinical benefit, uniform temperature profiles are desired within target volumes for 30 -60 min duration, with minimum temperature greater than 40 o C and 6 -10 min cumulative thermal dose at 43 o C. [3][4][5] Administering hyperthermia to tumors situated deep inside the body presents significant clinical challenges such as, selective energy deposition within the tumor while thermally sparing surrounding structures, and sufficient thermometry for reliable treatment monitoring. 6 These difficulties are also associated with hyperthermia delivery to focal tumors in prostate and other organs inside the pelvic cavity.…”
Section: Introductionmentioning
confidence: 99%
“…Devices designed for prostate hyperthermia include interstitial linear array applicators with tubular ultrasound transducers 5,7 and endorectal ultrasound (ERUS) phased arrays [8][9][10] used in combination with radiation therapy. Currently, MR guided high intensity focused ultrasound (HIFU) systems are being increasingly utilized for noninvasive or minimally-invasive thermal ablation of soft tissue tumors in multiple organ sites.…”
Section: Introductionmentioning
confidence: 99%
“…Thermotherapy significantly improves the efficacy of chemoradiotherapy and reduces its side effects so is often used in clinical practice. 7 Common methods of heating include hot water, 8,9 ultrasound, 10 and microwaves. 11 Kong et al were the first to study the effect of thermotherapy on carrier extravasation, 12 concluding that thermotherapy can improve the extravasation of liposomes.…”
Section: Introductionmentioning
confidence: 99%
“…62 Furthermore, in the in vivo setting we considered applicators consisting of 3 and 4 tubular ultrasound transducers in a linear array, similar in configurations as applied for hyperthermia with HDR brachytherapy. 63 We also included some simulations to approximate application of elevated power levels, where tissue temperatures in excess of 100…”
Section: Iid Bioacoustic-thermal Modelmentioning
confidence: 99%